VCV002159394.4 - ClinVar

NM_000030.3(AGXT):c.1161C>A (p.Cys387Ter)

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(3)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Pathogenic

criteria provided, multiple submitters, no conflicts

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_000030.3(AGXT):c.1161C>A (p.Cys387Ter)

Variation ID: 2159394 Accession: VCV002159394.4

Type and length

single nucleotide variant, 1 bp

Location

Cytogenetic: 2q37.3 2: 240878803 (GRCh38) [ NCBI UCSC ] 2: 241818220 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Feb 8, 2023	Oct 13, 2024	Oct 31, 2023

HGVS

Nucleotide	Protein	Molecular consequence
NM_000030.3:c.1161C>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.	NP_000021.1:p.Cys387Ter	nonsense
NC_000002.12:g.240878803C>A
NC_000002.11:g.241818220C>A
NG_008005.1:g.15059C>A

Protein change

C387*

Other names

Canonical SPDI

NC_000002.12:240878802:C:A

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
AGXT		-	-	GRCh38 GRCh37	914	1034

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
not provided	Pathogenic (1)	criteria provided, single submitter	Oct 31, 2023	RCV003072792.3
Primary hyperoxaluria, type I	Pathogenic (2)	criteria provided, single submitter	Jun 22, 2023	RCV003475507.2

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Pathogenic (Jun 22, 2023)	criteria provided, single submitter (ACMG Guidelines, 2015) Method: clinical testing	Primary hyperoxaluria, type I Affected status: unknown Allele origin: unknown	Baylor Genetics Accession: SCV004194839.1 First in ClinVar: Dec 30, 2023 Last updated: Dec 30, 2023
Pathogenic (Oct 31, 2023)	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015)) Method: clinical testing	not provided Affected status: unknown Allele origin: germline	Labcorp Genetics (formerly Invitae), Labcorp Accession: SCV003472717.2 First in ClinVar: Feb 07, 2023 Last updated: Feb 20, 2024	Publications: PubMed (2) PubMed: 30488096‚ 32556641 Comment: This sequence change creates a premature translational stop signal (p.Cys387) in the AGXT gene. While this is not anticipated to result in nonsense mediated decay, … (more) This sequence change creates a premature translational stop signal (p.Cys387) in the AGXT gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 6 amino acid(s) of the AGXT protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with primary hyperoxaluria (PMID: 30488096, 32556641). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 2159394). For these reasons, this variant has been classified as Pathogenic. (less)
Pathogenic (Aug 26, 2024)	no assertion criteria provided Method: clinical testing	Primary hyperoxaluria, type I Affected status: yes Allele origin: paternal	Chinese Inherited Urolithiasis Consortium, The Affiliated Yantai Yuhuangding Hospital of Qingdao University Accession: SCV005368530.1 First in ClinVar: Oct 13, 2024 Last updated: Oct 13, 2024	Comment: Variant_type:missense/MutationTaster:Disease_causing/CADD:Damaging/phyloP:Nonconserved/phastCons:Nonconserved/gnomAD_exome_EastAsian:-/ExAC_EastAsian:-/dbSNP:- Observation 1: Number of individuals with the variant: 1 Sex: male Ethnicity/Population group: Asian Geographic origin: China Observation 2: Number of individuals with the variant: 1 Sex: male Ethnicity/Population group: Asian Geographic origin: China Observation 3: Number of individuals with the variant: 1 Sex: female Ethnicity/Population group: Asian Geographic origin: China

Comment:

This sequence change creates a premature translational stop signal (p.Cys387*) in the AGXT gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 6 amino acid(s) of the AGXT protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with primary hyperoxaluria (PMID: 30488096, 32556641). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 2159394). For these reasons, this variant has been classified as Pathogenic.

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

Title	Author	Journal	Year	Link
Characteristics of the genotype and phenotype in Chinese primary hyperoxaluria type 1 populations.	Zhao F	Urolithiasis	2021	PMID: 32556641
Identification of 8 novel gene variants in primary hyperoxaluria in 21 Chinese children with urinary stones.	He L	World journal of urology	2019	PMID: 30488096

Text-mined citations for this variant ...

Record last updated Oct 13, 2024

ClinVar Genomic variation as it relates to human health

NM_000030.3(AGXT):c.1161C>A (p.Cys387Ter)

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...